These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3480670)

  • 21. [Measurement of CA 19-9 in patients with benign liver cyst].
    Okazaki K; Morita M; Sakamoto Y; Ido E; Fujikawa M
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jun; 81(6):1493. PubMed ID: 6590903
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M
    Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
    Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
    Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of biliary tract obstruction and cholangitis on serum CA 19-9 levels].
    Okaga M; Karasawa H; Kobayashi T; Satsukime N; Miki R
    Nihon Shokakibyo Gakkai Zasshi; 1985 May; 82(5):1418. PubMed ID: 3861895
    [No Abstract]   [Full Text] [Related]  

  • 25. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
    Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
    Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
    [No Abstract]   [Full Text] [Related]  

  • 26. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studying Australia antigen and measles antibody in chronic liver diseases].
    Szalay F; Büki B; Pallinger Z
    Orv Hetil; 1974 Jan; 115(3):135-7. PubMed ID: 4846866
    [No Abstract]   [Full Text] [Related]  

  • 28. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 30. CA-125 antigen in rhesus monkeys with spontaneous endometriosis.
    Pittaway DE; Klimek M; Koritnik DR
    Fertil Steril; 1986 Nov; 46(5):967-9. PubMed ID: 3465596
    [No Abstract]   [Full Text] [Related]  

  • 31. [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma].
    Röthlin M; Metzger U; Joller H; Largiadèr F
    Schweiz Med Wochenschr; 1988 Jun; 118(24):924-9. PubMed ID: 2456610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated carbohydrate antigens.
    Dabelsteen E; Clausen H
    J Oral Pathol; 1987 Apr; 16(4):196-8. PubMed ID: 3114459
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CA 15.3 levels in patients with non-tumoral diseases, and establishment of a threshold for tumoral activity. Results in 1219 patients.
    Ruibal A; Genollá J; Rosell M; Gris JM; Colomer R
    Int J Biol Markers; 1986; 1(3):159-60. PubMed ID: 3480917
    [No Abstract]   [Full Text] [Related]  

  • 35. [CA 19-9 in early cancers of the bronchi. Comparison with the carcinoembryogenic antigen].
    Vindimian M; Lafitte JJ; Wattre P
    Biomed Pharmacother; 1987; 41(4):191-5. PubMed ID: 3476162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of Ca (Oxford) antigen on placental trophoblast.
    Bishop PW; Malam JE; Morris JA; Fox H
    J Pathol; 1987 Feb; 151(2):119-23. PubMed ID: 3553505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of the determination of serum CA19.9 in patients with tumor or non-tumor pancreatopathies].
    Encabo G; Ruibal A; Gefaell R; Martínez Miralles E; Salgado A; Fernández Llamazares J
    Med Clin (Barc); 1984 Mar; 82(12):560-1. PubMed ID: 6588282
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunoreactivity of patients with pathology of the liver, gallbladder and biliary tract].
    Gredzhev AF; Trunova OA; Khatsko VV; Zorina SV
    Klin Khir (1962); 1990; (9):29-30. PubMed ID: 2273774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum CA-125 antigen levels increase during menses.
    Pittaway DE; Fayez JA
    Am J Obstet Gynecol; 1987 Jan; 156(1):75-6. PubMed ID: 3467595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.